AACR ANNUAL MEETING 2019
Join us in Chicago for this premiere meeting in oncology and get the latest on how to optimize oncology clinical trials in Canada
April 13-17, 2019
Whether you’re looking to expand an existing oncology trial due to slow recruitment or are planning to include Canada in an upcoming trial, the Reverse Feasibility Program is a sure way to connect you with sites that have proven they can deliver the results you’re looking for.
Here’s what the VP of Clinical Operations from one U.S. biotech had to say about his recent experience in Canada.
“Having recently expanded our Phase II trial to Canada through the Reverse Feasibility Program, we found that Canadian investigators were highly engaged in our studies. Their participation resulted in having our FPI (First Patient In) within 3 weeks and greatly contributed to being able to meet our enrolment objectives four months ahead of schedule.”
Call Nathan Currier today at (450) 629-2200 ext. 242 or fill out the form on the right to schedule a Discovery Meeting during the conference to discuss your expansion plans.